Hirofumi Michimae

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 468 citations

Gastrointestinal Oncology, Conventional Paclitaxel, Medicine +9

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

Kaoru Kubota, Hiroshi Sakai, Nobuyuki Katakami et al. · Annals of Oncology · 2015 · 88 citations · Full text

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Shoji Nagao, Shin Nishio, Hirofumi Michimae et al. · Gynecologic Oncology · 2013 · 75 citations

Sgsg-012/gotic-004/intergroup Study, Medicine, Cancer Management +7

A TADPOLE-INDUCED POLYPHENISM IN THE SALAMANDER HYNOBIUS RETARDATUS

Hirofumi Michimae, Masami Wakahara · Evolution · 2002 · 72 citations

Biology, Morphological Evidence, Natural Sciences +9

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression

Hiroyuki Nomura, Daisuke Aoki, Hirofumi Michimae et al. · JAMA Oncology · 2019 · 61 citations · Full text